Home/Filings/4/0000950170-25-010537
4//SEC Filing

Kowieski Mark 4

Accession 0000950170-25-010537

CIK 0001403708other

Filed

Jan 28, 7:00 PM ET

Accepted

Jan 29, 4:30 PM ET

Size

5.5 KB

Accession

0000950170-25-010537

Insider Transaction Report

Form 4
Period: 2025-01-28
Kowieski Mark
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2025-01-28+13,00013,000 total
    Exercise: $4.45Exp: 2035-01-27Common Stock (13,000 underlying)
Footnotes (1)
  • [F1]1/36th of the total number of shares subject to the options shall vest on each monthly anniversary of August 7, 2024 (the "Vesting Commencment Date"), subject to the Reporting Person's continuous service to the Issuer on each such vesting date, so that the options shall be fully vested on the third anniversary of the Vesting Commencement Date.

Documents

1 file

Issuer

Evoke Pharma Inc

CIK 0001403708

Entity typeother

Related Parties

1
  • filerCIK 0002024869

Filing Metadata

Form type
4
Filed
Jan 28, 7:00 PM ET
Accepted
Jan 29, 4:30 PM ET
Size
5.5 KB